University Professor Masia warns ‘340B has become a drug mark-up program’, as the 340B debate grows in Pennsylvania
Neal Masia, an adjunct professor at Columbia University, said recent research shows the expansion of the 340B Drug Pricing Program is largely driven by large teaching hospitals rather than smaller community-based providers, as similar concerns continue to emerge.







